CTOs on the Move

TruTag Technologies

www.trutags.com

 
At TruTag Technologies, we have devoted our energy and competency to developing a one-of-a-kind security solution to give brand owners the power to mitigate risks from counterfeiting and diversion in order to maintain the integrity of their brand and products. Our mission is to develop and apply cutting edge technology and innovative identification and security methods to offer the best product security platform in terms of quality, efficacy and safety for the protection of brands and consumers worldwide. We are driven to develop a full spectrum of market applications for the TruTag platform thereby making a greater impact on the prevention ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.trutags.com
  • 2045 Lauwiliwili Street Building 3
    Kapolei, HI USA 96707
  • Phone: 808.878.8247

Executives

Name Title Contact Details

Similar Companies

SV ChemBioTech

SV ChemBioTech, Inc. is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TLC Laser Eye Centers

TLC Laser Eye Centers is North America’s leading laser eye surgery provider, with more than 20 years of LASIK experience. Book a Free Consultation near you.

Vigil Neuroscience

Vigil Neuroscience is the world`s first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain`s immune system. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.

Horton and Converse Pharmacies

Horton and Converse Pharmacies is a Newport Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Astellas Pharma

Astellas Pharma US, Inc., a U.S. affiliate of Tokyo-based Astellas Pharma Inc., is a pharmaceutical company dedicated to changing tomorrow by improving the health of people around the world through innovative and reliable pharmaceutical products. In 2005, Astellas was formed by blending the talents, resources and passions of two highly successful firms - Yamanouchi and Fujisawa. Astellas aims to maintain and strengthen our position as the global leader in transplantation and urology areas, and going forward we are working to establish our position as a global category leader in oncology. At all levels throughout the company our people are committed to the opportunity to positively affect and improve patient lives while remaining socially responsible to our community and those with whom we work and collaborate.